The cost-effectiveness of returning incidental findings from next-generation genomic sequencing


Purpose:The American College of Medical Genetics and Genomics (ACMG) recommended that clinical laboratories performing next-generation sequencing analyze and return pathogenic variants for 56 specific genes it considered medically actionable. Our objective was to evaluate the clinical and economic impact of returning these results.Methods:We developed a… (More)
DOI: 10.1038/gim.2014.156


3 Figures and Tables


Citations per Year

Citation Velocity: 22

Averaging 22 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.